MINDBODY Inc (NASDAQ:MB) Director Adam L. Miller bought 3,000 shares of the firm’s stock in a transaction on Tuesday, August 14th. The stock was purchased at an average cost of $35.66 per share, with a total value of $106,980.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of NASDAQ MB opened at $36.30 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 9.61 and a quick ratio of 9.61. The company has a market cap of $1.72 billion, a P/E ratio of -121.00 and a beta of -0.16. MINDBODY Inc has a 12-month low of $21.57 and a 12-month high of $45.50.

MINDBODY (NASDAQ:MB) last announced its earnings results on Tuesday, July 31st. The technology company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.04). The business had revenue of $61.61 million for the quarter, compared to the consensus estimate of $60.48 million. MINDBODY had a negative net margin of 11.85% and a negative return on equity of 6.83%. equities research analysts anticipate that MINDBODY Inc will post -0.61 EPS for the current year.

Several research firms have recently weighed in on MB. Zacks Investment Research raised shares of MINDBODY from a “sell” rating to a “hold” rating in a report on Thursday, July 12th. Morgan Stanley boosted their price objective on shares of MINDBODY from $39.00 to $42.00 and gave the company an “equal weight” rating in a report on Wednesday, May 9th. BidaskClub raised shares of MINDBODY from a “buy” rating to a “strong-buy” rating in a report on Tuesday, May 8th. DA Davidson reissued a “buy” rating on shares of MINDBODY in a report on Wednesday, May 9th. Finally, ValuEngine raised shares of MINDBODY from a “buy” rating to a “strong-buy” rating in a report on Monday, May 7th. Four equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $37.77.

A number of hedge funds and other institutional investors have recently made changes to their positions in MB. MetLife Investment Advisors LLC bought a new stake in MINDBODY during the fourth quarter valued at approximately $609,000. Wells Fargo & Company MN grew its position in MINDBODY by 15.3% during the first quarter. Wells Fargo & Company MN now owns 78,315 shares of the technology company’s stock valued at $3,046,000 after buying an additional 10,396 shares during the period. SG Americas Securities LLC bought a new stake in MINDBODY during the first quarter valued at approximately $122,000. Capital Management Associates NY bought a new stake in MINDBODY during the first quarter valued at approximately $389,000. Finally, Trexquant Investment LP bought a new stake in MINDBODY during the first quarter valued at approximately $524,000. Institutional investors own 90.61% of the company’s stock.

About MINDBODY

MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.

Read More: Asset Allocation, Balancing Your Investments

Insider Buying and Selling by Quarter for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.